Bristol-Myers Squibb Company
BMY
$66.58
-$0.37-0.55%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 12.92% | -8.10% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 12.92% | -8.10% | |||
| Cost of Revenue | 8.89% | -2.82% | |||
| Gross Profit | 14.61% | -10.16% | |||
| SG&A Expenses | 13.29% | -22.86% | |||
| Depreciation & Amortization | 0.00% | -47.09% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.59% | -14.34% | |||
| Operating Income | 17.62% | 7.81% | |||
| Income Before Tax | 26.15% | 120.34% | |||
| Income Tax Expenses | 37.25% | 46.09% | |||
| Earnings from Continuing Operations | 23.82% | 146.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 200.00% | -200.00% | |||
| Net Income | 23.91% | 146.27% | |||
| EBIT | 17.62% | 7.81% | |||
| EBITDA | 15.18% | -3.04% | |||
| EPS Basic | 23.67% | 146.02% | |||
| Normalized Basic EPS | 18.80% | -5.60% | |||
| EPS Diluted | 23.66% | 147.40% | |||
| Normalized Diluted EPS | 18.97% | -5.79% | |||
| Average Basic Shares Outstanding | 0.20% | 0.10% | |||
| Average Diluted Shares Outstanding | 0.05% | 0.29% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.19% | -0.59% | |||